

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.41307342 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.50144983 |
| 3 | skeletal muscle tissue regeneration (GO:0043403) | 8.18295699 |
| 4 | plasma membrane repair (GO:0001778) | 8.09760234 |
| 5 | actin filament-based movement (GO:0030048) | 7.87870520 |
| 6 | myotube cell development (GO:0014904) | 7.25460315 |
| 7 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.07717328 |
| 8 | striated muscle contraction (GO:0006941) | 6.79793901 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.63230783 |
| 10 | sarcomere organization (GO:0045214) | 6.16986222 |
| 11 | response to inactivity (GO:0014854) | 6.08707240 |
| 12 | purine nucleotide salvage (GO:0032261) | 6.07524580 |
| 13 | creatine metabolic process (GO:0006600) | 6.00912827 |
| 14 | muscle contraction (GO:0006936) | 5.89347362 |
| 15 | glycogen catabolic process (GO:0005980) | 5.84243226 |
| 16 | muscle cell fate commitment (GO:0042693) | 5.75812679 |
| 17 | myofibril assembly (GO:0030239) | 5.67048928 |
| 18 | carnitine shuttle (GO:0006853) | 5.56354381 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.46585778 |
| 20 | glucan catabolic process (GO:0009251) | 5.46282659 |
| 21 | striated muscle atrophy (GO:0014891) | 5.36977729 |
| 22 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.20639253 |
| 23 | muscle system process (GO:0003012) | 5.18076674 |
| 24 | striated muscle adaptation (GO:0014888) | 5.10112099 |
| 25 | cellular polysaccharide catabolic process (GO:0044247) | 5.08344515 |
| 26 | glucan biosynthetic process (GO:0009250) | 5.07774368 |
| 27 | glycogen biosynthetic process (GO:0005978) | 5.07774368 |
| 28 | muscle fiber development (GO:0048747) | 5.01719051 |
| 29 | NADH metabolic process (GO:0006734) | 4.99218002 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 4.94925730 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.91920169 |
| 32 | polysaccharide catabolic process (GO:0000272) | 4.78602560 |
| 33 | response to muscle activity (GO:0014850) | 4.72255777 |
| 34 | IMP metabolic process (GO:0046040) | 4.70113870 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 4.68828500 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.66784373 |
| 37 | cytidine deamination (GO:0009972) | 4.65466296 |
| 38 | cytidine metabolic process (GO:0046087) | 4.65466296 |
| 39 | cytidine catabolic process (GO:0006216) | 4.65466296 |
| 40 | muscle atrophy (GO:0014889) | 4.65115970 |
| 41 | fructose metabolic process (GO:0006000) | 4.60244261 |
| 42 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.48997336 |
| 43 | striated muscle hypertrophy (GO:0014897) | 4.47747977 |
| 44 | actomyosin structure organization (GO:0031032) | 4.44638681 |
| 45 | regulation of myoblast differentiation (GO:0045661) | 4.41367626 |
| 46 | carnitine transmembrane transport (GO:1902603) | 4.36931406 |
| 47 | muscle organ morphogenesis (GO:0048644) | 4.36865342 |
| 48 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.34081796 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 4.31598250 |
| 50 | muscle organ development (GO:0007517) | 4.31003999 |
| 51 | neuromuscular synaptic transmission (GO:0007274) | 4.26925951 |
| 52 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.25078829 |
| 53 | muscle structure development (GO:0061061) | 4.24050353 |
| 54 | glycogen metabolic process (GO:0005977) | 4.22799886 |
| 55 | skeletal muscle cell differentiation (GO:0035914) | 4.21568696 |
| 56 | skeletal muscle tissue development (GO:0007519) | 4.20646921 |
| 57 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.16532738 |
| 58 | cellular glucan metabolic process (GO:0006073) | 4.14159059 |
| 59 | glucan metabolic process (GO:0044042) | 4.14159059 |
| 60 | muscle adaptation (GO:0043500) | 4.10612396 |
| 61 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.10184758 |
| 62 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.07705560 |
| 63 | muscle hypertrophy (GO:0014896) | 4.07278193 |
| 64 | gluconeogenesis (GO:0006094) | 4.03919455 |
| 65 | myotube differentiation (GO:0014902) | 4.03590295 |
| 66 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.03262436 |
| 67 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.01022954 |
| 68 | carnitine transport (GO:0015879) | 3.99473482 |
| 69 | amino-acid betaine transport (GO:0015838) | 3.99473482 |
| 70 | muscle tissue morphogenesis (GO:0060415) | 3.97842352 |
| 71 | neuronal action potential propagation (GO:0019227) | 3.92146658 |
| 72 | IMP biosynthetic process (GO:0006188) | 3.86001351 |
| 73 | adult heart development (GO:0007512) | 3.81127569 |
| 74 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.80543237 |
| 75 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.77242857 |
| 76 | positive regulation of myotube differentiation (GO:0010831) | 3.74809549 |
| 77 | muscle cell cellular homeostasis (GO:0046716) | 3.68736654 |
| 78 | striated muscle cell development (GO:0055002) | 3.66768611 |
| 79 | regulation of cofactor metabolic process (GO:0051193) | 3.64943838 |
| 80 | regulation of coenzyme metabolic process (GO:0051196) | 3.64943838 |
| 81 | hexose biosynthetic process (GO:0019319) | 3.61560284 |
| 82 | negative regulation of muscle contraction (GO:0045932) | 3.59962154 |
| 83 | ubiquinone biosynthetic process (GO:0006744) | 3.58160161 |
| 84 | cardiac muscle contraction (GO:0060048) | 3.56963096 |
| 85 | cardiac muscle adaptation (GO:0014887) | 3.55231165 |
| 86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.55231165 |
| 87 | muscle hypertrophy in response to stress (GO:0003299) | 3.55231165 |
| 88 | neuromuscular junction development (GO:0007528) | 3.53984602 |
| 89 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53510082 |
| 90 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53510082 |
| 91 | regulation of skeletal muscle fiber development (GO:0048742) | 3.53132830 |
| 92 | positive regulation of myoblast differentiation (GO:0045663) | 3.50740433 |
| 93 | cardiac muscle cell development (GO:0055013) | 3.49635314 |
| 94 | myoblast fusion (GO:0007520) | 3.48100167 |
| 95 | striated muscle tissue development (GO:0014706) | 3.40187172 |
| 96 | response to activity (GO:0014823) | 3.40100788 |
| 97 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.38395171 |
| 98 | regulation of myotube differentiation (GO:0010830) | 3.38236703 |
| 99 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.32265171 |
| 100 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.32265171 |
| 101 | negative regulation of myoblast differentiation (GO:0045662) | 3.31840993 |
| 102 | regulation of the force of heart contraction (GO:0002026) | 3.29999700 |
| 103 | cellular carbohydrate catabolic process (GO:0044275) | 3.29905871 |
| 104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.27314352 |
| 105 | regulation of relaxation of muscle (GO:1901077) | 3.26282423 |
| 106 | negative regulation of muscle hypertrophy (GO:0014741) | 3.25510450 |
| 107 | cellular response to dexamethasone stimulus (GO:0071549) | 3.24246540 |
| 108 | positive regulation of cation channel activity (GO:2001259) | 3.24016670 |
| 109 | relaxation of muscle (GO:0090075) | 3.23366202 |
| 110 | cardiac cell development (GO:0055006) | 3.22818351 |
| 111 | tricarboxylic acid cycle (GO:0006099) | 3.22654939 |
| 112 | AMP metabolic process (GO:0046033) | 3.19905273 |
| 113 | cardiac myofibril assembly (GO:0055003) | 3.19102915 |
| 114 | heart process (GO:0003015) | 3.18863910 |
| 115 | regulation of striated muscle contraction (GO:0006942) | 3.17425984 |
| 116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.16893924 |
| 117 | regulation of actin filament-based movement (GO:1903115) | 3.15362155 |
| 118 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.14365512 |
| 119 | syncytium formation (GO:0006949) | 3.06693433 |
| 120 | muscle cell development (GO:0055001) | 3.06114191 |
| 121 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.04995979 |
| 122 | muscle filament sliding (GO:0030049) | 12.9342038 |
| 123 | actin-myosin filament sliding (GO:0033275) | 12.9342038 |
| 124 | skeletal muscle contraction (GO:0003009) | 12.0403463 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 11.6928884 |
| 126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.8324204 |
| 127 | actin-mediated cell contraction (GO:0070252) | 10.6446974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.78072738 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.48603373 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.47152416 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08724485 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00601745 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43307010 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.33951098 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.29249111 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.19133487 |
| 10 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.10642164 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.10642164 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01612213 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97749053 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.91316131 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79034200 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75855130 |
| 17 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.75353105 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73997044 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72714787 |
| 20 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.70927359 |
| 21 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.70060815 |
| 22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.69073664 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66465306 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66213324 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.65329126 |
| 26 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.59133794 |
| 27 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.59133794 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.58978489 |
| 29 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.57468116 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53035268 |
| 31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46947527 |
| 32 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.44292129 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43732564 |
| 34 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36626611 |
| 35 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33576505 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33485334 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33287914 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32227009 |
| 39 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.30343671 |
| 40 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.30002738 |
| 41 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25512284 |
| 42 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.22519075 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20130865 |
| 44 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18581037 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18289478 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15618986 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13414674 |
| 48 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.11411728 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08178268 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08137103 |
| 51 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07967813 |
| 52 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06973065 |
| 53 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06817026 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06503262 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06097133 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06073188 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05987515 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05851341 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05268253 |
| 60 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03882419 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02290651 |
| 62 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01696322 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99979166 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97830037 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96908768 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96723856 |
| 67 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95888341 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95598284 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93599293 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93197522 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93197522 |
| 72 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.92768381 |
| 73 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91807009 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91668760 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91665159 |
| 76 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.91172622 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90917627 |
| 78 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.90617378 |
| 79 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90355765 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89914915 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89196036 |
| 82 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88702613 |
| 83 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.88316133 |
| 84 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.87713317 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87020562 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86709424 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86673228 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86579882 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86183432 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86156956 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85665253 |
| 92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85350300 |
| 93 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.84398552 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84390285 |
| 95 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84185352 |
| 96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84127520 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83786442 |
| 98 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.83125312 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81614081 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81143664 |
| 101 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80288962 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.79502034 |
| 103 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.79362551 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79176628 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79137646 |
| 106 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79053964 |
| 107 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.78883775 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78272253 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78027602 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77816364 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77696613 |
| 112 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.77573297 |
| 113 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.77573297 |
| 114 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.77311737 |
| 115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.77218785 |
| 116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76680128 |
| 117 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.76497962 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76230110 |
| 119 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.75976922 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74988280 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74705083 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74519988 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74444989 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74215808 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73751814 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.73560013 |
| 127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.73560013 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73512412 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.73149441 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.73127306 |
| 131 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.73089128 |
| 132 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.72508142 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.72314809 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.72175334 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71683906 |
| 136 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.71445108 |
| 137 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71391160 |
| 138 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71177158 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70440260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.10532960 |
| 2 | MP0003646_muscle_fatigue | 6.24704491 |
| 3 | MP0000749_muscle_degeneration | 6.16988089 |
| 4 | MP0000751_myopathy | 5.53519503 |
| 5 | MP0000747_muscle_weakness | 4.45756059 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.07431362 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.93091774 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.78585737 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.78443278 |
| 10 | MP0005451_abnormal_body_composition | 3.69683896 |
| 11 | MP0005369_muscle_phenotype | 3.53481351 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.45759655 |
| 13 | MP0002269_muscular_atrophy | 3.42094990 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.14298852 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.09509386 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.96414413 |
| 17 | MP0004130_abnormal_muscle_cell | 2.93074009 |
| 18 | MP0004233_abnormal_muscle_weight | 2.86435146 |
| 19 | MP0000733_abnormal_muscle_development | 2.86370741 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.41889759 |
| 21 | MP0005330_cardiomyopathy | 1.98095113 |
| 22 | MP0004270_analgesia | 1.91420328 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.86958280 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.82811468 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.80837297 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.66140419 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.58463097 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.45823421 |
| 29 | MP0005375_adipose_tissue_phenotype | 1.42954158 |
| 30 | MP0002971_abnormal_brown_adipose | 1.41294512 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.40062205 |
| 32 | MP0004484_altered_response_of | 1.39221583 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.38841147 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.22882293 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17240010 |
| 36 | MP0002822_catalepsy | 1.15863320 |
| 37 | MP0005266_abnormal_metabolism | 0.95769893 |
| 38 | MP0004134_abnormal_chest_morphology | 0.95673268 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 0.94023193 |
| 40 | MP0001661_extended_life_span | 0.91430147 |
| 41 | MP0003950_abnormal_plasma_membrane | 0.88284331 |
| 42 | MP0005385_cardiovascular_system_phenoty | 0.84402536 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 0.84402536 |
| 44 | MP0003137_abnormal_impulse_conducting | 0.82212974 |
| 45 | MP0002234_abnormal_pharynx_morphology | 0.80783208 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 0.79864933 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 0.66688558 |
| 48 | MP0004147_increased_porphyrin_level | 0.66312264 |
| 49 | MP0005670_abnormal_white_adipose | 0.65591620 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 0.64722283 |
| 51 | MP0000762_abnormal_tongue_morphology | 0.61844362 |
| 52 | MP0000372_irregular_coat_pigmentation | 0.59289298 |
| 53 | MP0003879_abnormal_hair_cell | 0.58408139 |
| 54 | MP0006138_congestive_heart_failure | 0.58241661 |
| 55 | MP0001299_abnormal_eye_distance/ | 0.54803035 |
| 56 | MP0004043_abnormal_pH_regulation | 0.54594223 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.54355702 |
| 58 | MP0009672_abnormal_birth_weight | 0.52914531 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 0.52302104 |
| 60 | MP0000266_abnormal_heart_morphology | 0.49989055 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.49854596 |
| 62 | MP0008961_abnormal_basal_metabolism | 0.49657712 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.49513039 |
| 64 | MP0008775_abnormal_heart_ventricle | 0.48836370 |
| 65 | MP0005334_abnormal_fat_pad | 0.48531213 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 0.46960040 |
| 67 | MP0001346_abnormal_lacrimal_gland | 0.42633466 |
| 68 | MP0005452_abnormal_adipose_tissue | 0.42370316 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41917914 |
| 70 | MP0000343_altered_response_to | 0.41227193 |
| 71 | MP0002638_abnormal_pupillary_reflex | 0.41078130 |
| 72 | MP0005083_abnormal_biliary_tract | 0.39777038 |
| 73 | MP0003828_pulmonary_edema | 0.38992852 |
| 74 | MP0001440_abnormal_grooming_behavior | 0.37993354 |
| 75 | MP0002114_abnormal_axial_skeleton | 0.37290439 |
| 76 | MP0004085_abnormal_heartbeat | 0.37090523 |
| 77 | MP0002734_abnormal_mechanical_nocicepti | 0.36769391 |
| 78 | MP0005166_decreased_susceptibility_to | 0.36371297 |
| 79 | MP0000230_abnormal_systemic_arterial | 0.35182378 |
| 80 | MP0005187_abnormal_penis_morphology | 0.34634350 |
| 81 | MP0004142_abnormal_muscle_tone | 0.34257390 |
| 82 | MP0008569_lethality_at_weaning | 0.34232780 |
| 83 | MP0009115_abnormal_fat_cell | 0.33698529 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.32364013 |
| 85 | MP0005332_abnormal_amino_acid | 0.31757775 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.31015160 |
| 87 | MP0001943_abnormal_respiration | 0.29097963 |
| 88 | MP0003959_abnormal_lean_body | 0.28611800 |
| 89 | MP0004510_myositis | 0.28177868 |
| 90 | MP0008874_decreased_physiological_sensi | 0.27170968 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.27109974 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.26464352 |
| 93 | MP0005423_abnormal_somatic_nervous | 0.25089874 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 0.24978392 |
| 95 | MP0003948_abnormal_gas_homeostasis | 0.24793225 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.24600785 |
| 97 | MP0004858_abnormal_nervous_system | 0.24039559 |
| 98 | MP0002067_abnormal_sensory_capabilities | 0.23261059 |
| 99 | MP0002128_abnormal_blood_circulation | 0.22313433 |
| 100 | MP0009840_abnormal_foam_cell | 0.20743151 |
| 101 | MP0005535_abnormal_body_temperature | 0.20411756 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.19113823 |
| 103 | MP0001851_eye_inflammation | 0.18913071 |
| 104 | MP0003385_abnormal_body_wall | 0.18266772 |
| 105 | MP0005386_behavior/neurological_phenoty | 0.18041898 |
| 106 | MP0004924_abnormal_behavior | 0.18041898 |
| 107 | MP0003690_abnormal_glial_cell | 0.17478462 |
| 108 | MP0002932_abnormal_joint_morphology | 0.16697149 |
| 109 | MP0006276_abnormal_autonomic_nervous | 0.16205041 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.15941542 |
| 111 | MP0003045_fibrosis | 0.15776054 |
| 112 | MP0005645_abnormal_hypothalamus_physiol | 0.14751258 |
| 113 | MP0005165_increased_susceptibility_to | 0.14182828 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.13550825 |
| 115 | MP0003956_abnormal_body_size | 0.13289942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 8.06354146 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 7.99754007 |
| 3 | Distal arthrogryposis (HP:0005684) | 7.14459149 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.02743786 |
| 5 | Myopathic facies (HP:0002058) | 6.61481492 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.12577028 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 5.90762947 |
| 8 | Round ear (HP:0100830) | 5.89913949 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 5.43817242 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.22292744 |
| 11 | Calcaneovalgus deformity (HP:0001848) | 5.07367866 |
| 12 | Deformed tarsal bones (HP:0008119) | 5.01818251 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.93564516 |
| 14 | Difficulty running (HP:0009046) | 4.89966049 |
| 15 | Myoglobinuria (HP:0002913) | 4.64888589 |
| 16 | Muscle stiffness (HP:0003552) | 4.60284519 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.58907562 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.48422923 |
| 19 | Malignant hyperthermia (HP:0002047) | 3.97986669 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.97555303 |
| 21 | Increased connective tissue (HP:0009025) | 3.97203936 |
| 22 | Myotonia (HP:0002486) | 3.94749387 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 3.84734407 |
| 24 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.82801818 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 3.79371598 |
| 26 | Neck muscle weakness (HP:0000467) | 3.58014926 |
| 27 | Areflexia of lower limbs (HP:0002522) | 3.48746992 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.44064843 |
| 29 | Fatigable weakness (HP:0003473) | 3.43959977 |
| 30 | Abnormality of the neuromuscular junction (HP:0003398) | 3.43959977 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29527647 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.27712355 |
| 33 | Frequent falls (HP:0002359) | 3.23993598 |
| 34 | Difficulty climbing stairs (HP:0003551) | 3.06121367 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.03630386 |
| 36 | Subaortic stenosis (HP:0001682) | 3.03630386 |
| 37 | Pelvic girdle muscle weakness (HP:0003749) | 3.02597549 |
| 38 | Abnormality of the calcaneus (HP:0008364) | 2.98153168 |
| 39 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.90766151 |
| 40 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.90766151 |
| 41 | Fetal akinesia sequence (HP:0001989) | 2.90241574 |
| 42 | Shoulder girdle muscle weakness (HP:0003547) | 2.86460132 |
| 43 | Hyperkalemia (HP:0002153) | 2.85791427 |
| 44 | Weak cry (HP:0001612) | 2.82892064 |
| 45 | Bulbar palsy (HP:0001283) | 2.82411946 |
| 46 | Bundle branch block (HP:0011710) | 2.79430215 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.73902261 |
| 48 | Slender build (HP:0001533) | 2.56617125 |
| 49 | Generalized muscle weakness (HP:0003324) | 2.53125516 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.52340815 |
| 51 | Gowers sign (HP:0003391) | 2.48316333 |
| 52 | Nonprogressive disorder (HP:0003680) | 2.45182576 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 2.44488397 |
| 54 | Facial diplegia (HP:0001349) | 2.41457369 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36795434 |
| 56 | Ulnar deviation of finger (HP:0009465) | 2.31833258 |
| 57 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29101933 |
| 58 | Sudden death (HP:0001699) | 2.28722301 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.27870327 |
| 60 | Paralysis (HP:0003470) | 2.27499245 |
| 61 | Proximal amyotrophy (HP:0007126) | 2.22478389 |
| 62 | Muscle fiber atrophy (HP:0100295) | 2.17974096 |
| 63 | Muscular dystrophy (HP:0003560) | 2.13728058 |
| 64 | Spinal rigidity (HP:0003306) | 2.08396978 |
| 65 | Limb-girdle muscle atrophy (HP:0003797) | 2.06826873 |
| 66 | Limb-girdle muscle weakness (HP:0003325) | 2.06729287 |
| 67 | Scapular winging (HP:0003691) | 2.04227844 |
| 68 | Lipoatrophy (HP:0100578) | 2.02040111 |
| 69 | Distal lower limb amyotrophy (HP:0008944) | 2.00790694 |
| 70 | Metatarsus adductus (HP:0001840) | 2.00229367 |
| 71 | Muscle fiber inclusion bodies (HP:0100299) | 11.0131597 |
| 72 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.4567546 |
| 73 | Nemaline bodies (HP:0003798) | 10.1610495 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 1.99449531 |
| 75 | Hip contracture (HP:0003273) | 1.96841472 |
| 76 | Hypoplastic ischia (HP:0003175) | 1.96487254 |
| 77 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96055236 |
| 78 | Easy fatigability (HP:0003388) | 1.91795732 |
| 79 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.91767776 |
| 80 | Exercise intolerance (HP:0003546) | 1.86576219 |
| 81 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84478755 |
| 82 | Heart block (HP:0012722) | 1.83784543 |
| 83 | Waddling gait (HP:0002515) | 1.83582621 |
| 84 | Foot dorsiflexor weakness (HP:0009027) | 1.81505566 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 1.80040732 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74888269 |
| 87 | Abnormal atrioventricular conduction (HP:0005150) | 1.71272882 |
| 88 | Abnormality of the ischium (HP:0003174) | 1.69225722 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.66421252 |
| 90 | Popliteal pterygium (HP:0009756) | 1.62261086 |
| 91 | Synostosis involving bones of the feet (HP:0009140) | 1.60725269 |
| 92 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.60725269 |
| 93 | Tarsal synostosis (HP:0008368) | 1.60625693 |
| 94 | Increased muscle lipid content (HP:0009058) | 1.59912514 |
| 95 | Achilles tendon contracture (HP:0001771) | 1.57902346 |
| 96 | Short palpebral fissure (HP:0012745) | 1.52809471 |
| 97 | Mesomelia (HP:0003027) | 1.52068166 |
| 98 | Lower limb amyotrophy (HP:0007210) | 1.51557225 |
| 99 | Stridor (HP:0010307) | 1.51463326 |
| 100 | Abnormality of potassium homeostasis (HP:0011042) | 1.51450959 |
| 101 | Ventricular arrhythmia (HP:0004308) | 1.50939024 |
| 102 | Fibular aplasia (HP:0002990) | 1.50484212 |
| 103 | Ventricular tachycardia (HP:0004756) | 1.48476075 |
| 104 | Adducted thumb (HP:0001181) | 1.44309697 |
| 105 | Congenital hip dislocation (HP:0001374) | 1.43620804 |
| 106 | Cholelithiasis (HP:0001081) | 1.43612049 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.43104740 |
| 108 | Dilated cardiomyopathy (HP:0001644) | 1.39892231 |
| 109 | Amniotic constriction ring (HP:0009775) | 1.38056658 |
| 110 | Abnormality of placental membranes (HP:0011409) | 1.38056658 |
| 111 | Long clavicles (HP:0000890) | 1.37396452 |
| 112 | Limited hip movement (HP:0008800) | 1.35712763 |
| 113 | Steppage gait (HP:0003376) | 1.26853650 |
| 114 | Oligomenorrhea (HP:0000876) | 1.25073292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.36736926 |
| 2 | TTN | 5.12717540 |
| 3 | PHKG1 | 4.74473245 |
| 4 | PHKG2 | 4.74473245 |
| 5 | NME1 | 4.16275894 |
| 6 | PIK3CG | 3.54026620 |
| 7 | PDK2 | 2.91427387 |
| 8 | MUSK | 2.88625687 |
| 9 | MAP2K3 | 2.50014093 |
| 10 | PINK1 | 2.34148666 |
| 11 | NEK9 | 2.21397850 |
| 12 | TRIB3 | 2.16899729 |
| 13 | NEK1 | 2.15760539 |
| 14 | PDK4 | 2.11709189 |
| 15 | PDK3 | 2.11709189 |
| 16 | MAP3K7 | 2.08243107 |
| 17 | MAPK12 | 1.82534005 |
| 18 | MAP2K4 | 1.71299745 |
| 19 | DMPK | 1.54813444 |
| 20 | BCKDK | 1.39960181 |
| 21 | MAP2K6 | 1.32726214 |
| 22 | PIK3CA | 1.24837863 |
| 23 | ERBB3 | 1.08454929 |
| 24 | ZAK | 1.02504630 |
| 25 | AKT2 | 0.93384770 |
| 26 | MARK1 | 0.88604317 |
| 27 | MAP3K13 | 0.82956538 |
| 28 | PRKAA2 | 0.79488858 |
| 29 | CAMK2G | 0.72138578 |
| 30 | MAP3K6 | 0.69941805 |
| 31 | PKN2 | 0.67829955 |
| 32 | MAPK7 | 0.61605642 |
| 33 | PRKAA1 | 0.61112500 |
| 34 | CAMK4 | 0.58609986 |
| 35 | MAPK11 | 0.55494973 |
| 36 | MAP2K1 | 0.54856687 |
| 37 | MAP3K11 | 0.49828772 |
| 38 | MOS | 0.45725721 |
| 39 | MAP3K3 | 0.43721948 |
| 40 | TRPM7 | 0.42542823 |
| 41 | CAMK1 | 0.42241419 |
| 42 | ERN1 | 0.41418156 |
| 43 | INSRR | 0.40948737 |
| 44 | TAOK2 | 0.40456418 |
| 45 | TBK1 | 0.40320660 |
| 46 | ILK | 0.39748216 |
| 47 | KSR2 | 0.38866844 |
| 48 | MAP3K5 | 0.38549409 |
| 49 | MAPKAPK3 | 0.37128554 |
| 50 | PKN1 | 0.36788483 |
| 51 | EPHB1 | 0.36471189 |
| 52 | PDPK1 | 0.36295242 |
| 53 | CDK8 | 0.35002368 |
| 54 | PDK1 | 0.34584052 |
| 55 | SGK1 | 0.34332423 |
| 56 | TAOK1 | 0.34027434 |
| 57 | CAMK2D | 0.31626783 |
| 58 | PRKG1 | 0.31616734 |
| 59 | ARAF | 0.31115380 |
| 60 | STK24 | 0.29705965 |
| 61 | BMPR2 | 0.29297341 |
| 62 | TIE1 | 0.28293136 |
| 63 | PRKACB | 0.27824516 |
| 64 | MAP3K4 | 0.26727693 |
| 65 | NEK6 | 0.25981894 |
| 66 | RPS6KB2 | 0.25354655 |
| 67 | SGK2 | 0.24906713 |
| 68 | LIMK1 | 0.24203858 |
| 69 | RPS6KA3 | 0.21825545 |
| 70 | DAPK2 | 0.21812869 |
| 71 | NTRK3 | 0.21697552 |
| 72 | RIPK1 | 0.21653905 |
| 73 | PAK6 | 0.20946244 |
| 74 | RPS6KA1 | 0.20847658 |
| 75 | CCNB1 | 0.20719336 |
| 76 | ROCK1 | 0.19945353 |
| 77 | ICK | 0.19752435 |
| 78 | RPS6KB1 | 0.19695796 |
| 79 | CDK6 | 0.19561683 |
| 80 | EPHA4 | 0.19024202 |
| 81 | MAPK10 | 0.18562752 |
| 82 | PTK6 | 0.17847436 |
| 83 | TYK2 | 0.17025005 |
| 84 | DYRK3 | 0.16771296 |
| 85 | PRKACA | 0.16613929 |
| 86 | SIK1 | 0.16344829 |
| 87 | MAP3K1 | 0.15392989 |
| 88 | ZAP70 | 0.15159833 |
| 89 | MAPK4 | 0.14603551 |
| 90 | RPS6KA6 | 0.13293096 |
| 91 | RPS6KC1 | 0.13236992 |
| 92 | RPS6KL1 | 0.13236992 |
| 93 | CDK19 | 0.12633395 |
| 94 | GRK1 | 0.11438475 |
| 95 | DYRK1B | 0.11101110 |
| 96 | FER | 0.10812156 |
| 97 | TNK2 | 0.10638186 |
| 98 | MARK2 | 0.10502060 |
| 99 | HIPK2 | 0.09772597 |
| 100 | SGK3 | 0.09658899 |
| 101 | RPS6KA2 | 0.09182941 |
| 102 | ABL2 | 0.09169987 |
| 103 | MAP3K9 | 0.08964673 |
| 104 | EEF2K | 0.08889181 |
| 105 | MTOR | 0.08136098 |
| 106 | MAP2K7 | 0.07882344 |
| 107 | BRAF | 0.07874115 |
| 108 | PRPF4B | 0.07760525 |
| 109 | SGK494 | 0.07491361 |
| 110 | SGK223 | 0.07491361 |
| 111 | MARK3 | 0.06774992 |
| 112 | STK11 | 0.06614917 |
| 113 | TXK | 0.05463363 |
| 114 | KSR1 | 0.05312513 |
| 115 | CSNK1D | 0.04460389 |
| 116 | CAMK2B | 0.04289182 |
| 117 | FLT3 | 0.04150274 |
| 118 | PRKD1 | 0.03725798 |
| 119 | CAMK2A | 0.03400234 |
| 120 | STK38 | 0.03313783 |
| 121 | MAPK9 | 0.02037436 |
| 122 | CDK9 | 0.01998846 |
| 123 | MAPK8 | 0.00431123 |
| 124 | RAF1 | 0.00274362 |
| 125 | PRKACG | -0.0176091 |
| 126 | LATS2 | -0.0147350 |
| 127 | GSK3A | -0.0128068 |
| 128 | MAPK13 | -0.0084194 |
| 129 | PRKCA | -0.0051948 |
| 130 | MAP3K10 | -0.0001933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.54697927 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.01923800 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.91141315 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.85567124 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.70555160 |
| 6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.15576972 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.72247076 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.53839256 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45095216 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.41674327 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.39800465 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.24981702 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.95688903 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.90016900 |
| 15 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.87627657 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85850340 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.71607599 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54486113 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52839862 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49648068 |
| 21 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.49498124 |
| 22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.48475179 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38923448 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38069103 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35820524 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30822118 |
| 27 | Tight junction_Homo sapiens_hsa04530 | 1.28631692 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27003008 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.25584214 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25218786 |
| 31 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.25197767 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.25135760 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24435006 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22193517 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12869030 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12082563 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.10058529 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98931985 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98259278 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97761817 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.96664306 |
| 42 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.95946271 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92818395 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 0.92549583 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 0.86682723 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86499472 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85183015 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81077662 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.79481155 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78527139 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77204970 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76255308 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68869641 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65763341 |
| 55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65476877 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64859721 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62299435 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58500742 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57598001 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 0.56010989 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54840144 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48274256 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48195706 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47922104 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47404231 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47264930 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46998690 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46085195 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45676222 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.45525829 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44797796 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44419136 |
| 73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41013552 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40507197 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.36831665 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36824543 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35680636 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35604067 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35410957 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34920138 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32511640 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32139009 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.31978547 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31967010 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31475230 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28824372 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28598731 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28396302 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27618053 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26990363 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24411334 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24212450 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23767199 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23691933 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.22631942 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22067344 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21097901 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.20736314 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.20698845 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.20035377 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.19396162 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18909585 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18513462 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15548488 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15435189 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15287119 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.14417818 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14041310 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13396809 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13206499 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12625725 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12420650 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11859999 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.11771588 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11308305 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.10610471 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08507255 |
| 118 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.08043644 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.07868934 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.07071520 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.07020788 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.06755289 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.06738308 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.06302718 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.05497964 |
| 126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.01794585 |

